Most cited papers from Serimmune (United States)

Serimmune (United States)

What are the most cited papers from Serimmune (United States)?

The most cited paper from Serimmune (United States) is "Distinguishing features of long COVID identified through immune profiling" (Jon Klein et al., 2023), with 723 citations. Next come "Real-Time Reverse Transcriptase PCR Assay for Detection of Human Metapneumoviruses from All Known Genetic Lineages" (327) and "Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study" (280).

Published TypeFieldAccessCitations

Showing 50 of 59 papers. Every paper with more than 34 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Distinguishing features of long COVID identified through immune profiling Jon Klein et al. · Nature Open access	25 Sep 2023	723
2	Real-Time Reverse Transcriptase PCR Assay for Detection of Human Metapneumoviruses from All Known Genetic Lineages Jeroen Maertzdorf, Chiaoyin K. Wang, Jennifer B. Brown et al. · Journal of Clinical Microbiology Open access	Mar 2004	327
3	Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study Bruce E. Sands, Jingjing Chen, Brian G. Feagan et al. · Gastroenterology Open access	5 Apr 2017	280
4	Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia Robert J. Kreitman et al. · Leukemia Open access	20 Jul 2018	253
5	Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Todd M. Allen, Thorsten U. Vogel, DEBORAH HEYDENBURG FULLER et al. · The Journal of Immunology	May 2000	251
6	Benralizumab for PDGFRA -Negative Hypereosinophilic Syndrome Fei Li Kuang et al. · New England Journal of Medicine Open access	3 Apr 2019	220
7	Identification of New HER2/ neu- Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas Rongcun Yang, Flavio Salazar‐Onfray, Jehad Charo et al. · The Journal of Immunology	Jul 1999	174
8	A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity Christopher R. Cotter, Hong Jin, Yuyan Chen · PLoS Pathogens Open access	2 Jan 2014	162
9	Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status Paul Baverel, Vincent F. S. Dubois, Chao Yu Jin et al. · Clinical Pharmacology & Therapeutics Open access	16 Dec 2017	158
10	Oral peptide delivery: Translational challenges due to physiological effects Puneet Tyagi, Sergei Pechenov, J. Anand Subramony · Journal of Controlled Release	23 Aug 2018	156
11	Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults Omar Ali, Xiang‐Qing Yu, Gabriel J. Robbie et al. · Clinical Microbiology and Infection Open access	11 Aug 2018	135
12	A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis Gerd Rüdiger Burmester, Iain B. McInnes, Joel M. Kremer et al. · Annals of the Rheumatic Diseases Open access	17 Feb 2017	129
13	The role of nasal IgA in children vaccinated with live attenuated influenza vaccine Christopher S. Ambrose, Xionghua Wu, Taff Jones et al. · Vaccine Open access	18 Sep 2012	117
14	Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 Lewis Au et al. · Nature Medicine Open access	26 May 2021	103
15	Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis Rosa Rodríguez Fernández, Lorena I. Tapia, Chin-Fen Yang et al. · The Journal of Infectious Diseases Open access	8 Oct 2017	101
16	Avian Influenza H6 Viruses Productively Infect and Cause Illness in Mice and Ferrets Laura Gillim-Ross, Celia P. Santos, Yuyan Chen et al. · Journal of Virology Open access	21 Aug 2008	100
17	H5N1 vaccines in humans Mariana Baz, Catherine J. Luke, Xing Cheng et al. · Virus Research Open access	28 May 2013	97
18	A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults Kawsar R. Talaat, Ruth A. Karron, Karen A. Callahan et al. · Vaccine Open access	18 Apr 2009	90
19	HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients Sandra R. Reynolds, Esteban Celis, Alessandro Sette et al. · The Journal of Immunology	Dec 1998	87
20	Evaluation of the Humoral and Cellular Immune Responses Elicited by the Live Attenuated and Inactivated Influenza Vaccines and Their Roles in Heterologous Protection in Ferrets Xing Cheng, James R. Zengel, Amorsolo L. Suguitan et al. · The Journal of Infectious Diseases Open access	8 May 2013	87
21	Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age Elissa M. Malkin, Ram Yogev, Nazha Abughali et al. · PLoS ONE Open access	29 Oct 2013	84
22	Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy Xing Cheng, Weijia Wang, Qi Xu et al. · Journal of Virology Open access	24 Mar 2016	82
23	Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small Puneet Tyagi, J. Anand Subramony · Journal of Controlled Release	19 Jan 2018	76
24	Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets Yuyan Chen, Mariana Baz, Janine Lu et al. · Journal of Virology Open access	10 Apr 2014	73
25	A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets Tomy Joseph, Josephine M. McAuliffe, Bin Lü et al. · Virology Open access	28 Jun 2008	72
26	Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893 David E. Tabor, Li Yu, Hoyin Mok et al. · Antimicrobial Agents and Chemotherapy Open access	22 Jun 2016	63
27	A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties Andrew C. Nyborg et al. · PLoS ONE Open access	21 Dec 2016	62
28	Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing Rubén O. Donis et al. · Vaccine Open access	24 Jun 2014	62
29	Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma Yanan Zheng, Rajesh Narwal, ChaoYu Jin et al. · Clinical Pharmacology & Therapeutics Open access	16 Dec 2017	58
30	High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19 Winston A. Haynes et al. · Communications Biology Open access	22 Nov 2021	57
31	Plasmablast-derived polyclonal antibody response after influenza vaccination Xiaosong He, Sanae Sasaki, Carlos Fernando Narváez et al. · Journal of Immunological Methods Open access	22 Dec 2010	57
32	2018 White Paper on Recent Issues in Bioanalysis: Focus on Flow Cytometry, Gene Therapy, Cut Points and Key Clarifications on Bav (Part 3 – Lba/Cell-Based Assays: Immunogenicity, Biomarkers and Pk Assays) Lauren F. Stevenson et al. · Bioanalysis	29 Nov 2018	55
33	Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV Wei Bu, Gregory M. Hayes, Hui Liu et al. · Clinical and Vaccine Immunology Open access	18 Feb 2016	52
34	Evaluation of Live Attenuated Influenza A Virus H6 Vaccines in Mice and Ferrets Yuyan Chen, Celia P. Santos, Amy Aspelund et al. · Journal of Virology Open access	23 Oct 2008	52
35	Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A Stacie L. Lambert, Chin‐Fen Yang, Zheng Liu et al. · PLoS ONE Open access	28 Dec 2012	51
36	High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells Jennifer Chen et al. · Science Immunology Open access	4 Feb 2022	49
37	Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells Corinne Cayatte, Kirsten Schneider-Ohrum, Zhaoti Wang et al. · Journal of Virology Open access	8 Aug 2013	49
38	A Live Attenuated H7N7 Candidate Vaccine Virus Induces Neutralizing Antibody That Confers Protection from Challenge in Mice, Ferrets, and Monkeys Ji-Young Min, Leatrice Vogel, Yumiko Matsuoka et al. · Journal of Virology Open access	2 Sep 2010	48
39	Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein Sarah Lapidus et al. · Scientific Reports Open access	22 Dec 2022	47
40	Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia Binh An Diep, Jamese J. Hilliard, Vien T. M. Le et al. · Antimicrobial Agents and Chemotherapy Open access	24 Jan 2017	47
41	Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation Benjamin Ribba, H. P. Grimm, Balaji M. Agoram et al. · CPT Pharmacometrics & Systems Pharmacology Open access	6 Jun 2017	46
42	Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters Jeanne H. Schickli, Jasmine Kaur, Mia MacPhail et al. · Virology Journal Open access	2008	46
43	Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T Tanya Barauskas Dorff, Yosuke Hirasawa, Jared David Acoba et al. · Journal for ImmunoTherapy of Cancer Open access	Aug 2021	44
44	Identification of disease-specific motifs in the antibody specificity repertoire via next-generation sequencing Robert J. Pantazes, Jack R. Reifert, Joel D. Bozekowski et al. · Scientific Reports Open access	2 Aug 2016	44
45	Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology Kathy Kamath, Jack R. Reifert, Timothy S. Johnston et al. · Scientific Reports Open access	24 Mar 2020	43
46	Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase Udaya Shankari Rangaswamy, Weijia Wang, Xing Cheng et al. · Journal of Virology Open access	8 Jun 2017	43
47	Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets Grace L. Chen, Elaine W. Lamirande, Chin‐Fen Yang et al. · Journal of Virology Open access	27 May 2010	43
48	The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets Yuyan Chen, Lomi Kim, Kanta Subbarao et al. · Vaccine Open access	11 Feb 2012	42
49	Cloning and assessment of tumorigenicity and oncogenicity of a Madin–Darby canine kidney (MDCK) cell line for influenza vaccine production Jonathan Liu, Sachin Mani, Richard M. Schwartz et al. · Vaccine	28 Nov 2009	42
50	An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults Kawsar R. Talaat, Ruth A. Karron, Catherine J. Luke et al. · Vaccine Open access	5 Mar 2011	42

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.